New IDSA recommendation: In hospitalized on systemic steroids w/ severe, critical, progressing COVID-19, when baricitinib or tocilizumab are not available, IDSA guideline panel suggests infliximab. https://t.co/ZCkkZXUDpi https://t.co/gbgkvj5R8Y
Links:
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of A…
https://buff.ly/KzpuAox
22-08-2025
